Is there a relationship between the intensity of heparin treatment and recurrent thomboembolism?

Clinical and Applied Thrombosis/Hemostasis

Volumn 3, Issue 1 SUPPL., 1997, Pages

  Anand, Sonia ^a   Ginsberg, Jeffrey S ^a   Hirsh, Jack ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Activated partial thromboplastin time; Recurrence; Unfractionated heparin; Venous thromboemblism

Indexed keywords

EID: 33847576926     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029697003001s09     Document Type: Article

References (20)

1. Hirsh J. Antithrombotic therapy in deep vein thrombosis and pulmonary embolism. Am Heart J 1992;123:1115-22.
2. Hull RD Raskob GE, Pineo GF,et al.Subcutaneous low molecular weight heparin compared with continuous intravenous heparin in the treatment of proximal vein thrombosis. N Engl J Med 1992; 326:975-82.
3. Lensing AW, Prins MH, Davidson BL,et al.Treatment of deep venous thrombosis with low molecular weight heparin: A meta-analysis. Arch Intern Med 1994;155:601-7.
4. Barrit DW, Jordan SC Anticoagulant drugs in the treatment of pulmonary embolism: A controlled clinical trial. Lancet 1960;1: 1309-12.
5. Brandjes DP, Heijboer H., Buller HR, DeRijk M. Jagt H., ten Cate JW Acencoumarol and heparin compared with acencoumarol alone in the initial treatment of proximal-vein thrombosis. N Engl J Med 1992:327:1485-9:.
6. Hull RD, Raskob GE, Hirsh J.,et al.Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal vein thrombosis. N Engl J Med 1986;315: 1109-14.
7. Levine MN, Hirsh J., Gent M.,et al.A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Intern Med 1994; 154:49-56,.
8. Chiu HM, Hirsh J., Yung WL,et al.Relationship between anticoagulant and antithrombotic effects of heparin. Blood 1987;49: 171-84.
9. Basu D., Gallus A., Hirsh J., Cade J. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 1972;287:324-7.
10. Brill-Edwards P., Ginsberg JS, Johnston M., Hirsh J. Establishing a therapeutic range for heparin therapy. Ann Intern Med 1993; 119: 104-9.
11. Turpie AG, Robinson JG, Doyle DJ,et al.Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. N Engl J Med 1989;320:352-94.
12. Levine MW, Raskob G., Landefeld S., Hirsh J. Haemorrhagic complications of anticoagulant treatment Chest 1995;108:276S-90S.
13. Elliot CG, Hiltunen SJ, Suchyta M.,et al.Physician-guided treatment compared with a heparin protocol for deep vein thrombosis. Arch Intern Med 1994;154:999-1004.
14. Hull RD, Raskob GE, Rosenbloom D.,et al.Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990;322:1260-4.
15. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a standard care nomogram. Ann Intern Med 1993;119:874-81.
16. Prandoni P., Lensing AW, Buller HR,et al.Comparison of subcutaneous low molecular weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet 1992;339:441-5.
17. Simonneau G., Charbonnier B., Decousus H.,et al.Subcutaneous low-molecular weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Arch Intern Med 1993;153:1541-6.
18. Anand S., Ginsberg JS, Kearon C., Hirsh J. The relationship between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin. J Gen Intern Med 1995; 10(suppl 4):38.
19. Cruickshank MK, Levine MN, Hirsh J.,et al.A standard heparin nomogram for the management of heparin therapy. Arch Intern Med 1991;151:333-7.
20. Hull RD, Raskob GE, Rosenbloom D.,et al.Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med 1992;152:1589-95.